@article{8e565440b98c4935bb5c6b203d7020cc,
title = "Top research priorities for stroke genetics",
author = "Daniel Woo and Anderson, {Christopher D.} and Jane Maguire and Myriam Fornage and Lee, {Jin Moo} and Sudha Seshadri and Markus, {Hugh S.} and Majersik, {Jennifer J.} and Jordi Jimenez-Conde and Katherine Crawford and Lindgren, {Arne G.} and Stephanie Debette",
note = "Funding Information: DW is supported by NIH U10NS077311, U01NS036695, R01NS093870, and R01NS100417 funding. CDA is supported by NIH/NINDS K23NS086873, R01NS103924, and has consulted for ApoPharma Inc. MF is supported by NIH/NINDS R01NS087541 funding. J-ML is supported by NIH/NINDS R21AG055333, R01NS084028, R01NS085419, and R01NS094692 funding. SS is supported by NIH R01AG033193, U01AG049505, R01AG049607, R01AG033040, U01AG52409, R01AG054076, R01NS017950, and UH2NS100605 funding. HSM is supported by an NIHR Senior Investigator award and his work is supported by infrastructural support by the Cambridge University NHS Trust NIHR Biomedical Research Centre. JM is supported by NIH/NINDS U10NS086606 funding. AGL is supported by the Swedish Heart Lung Foundation, Lund University, Region Sk{\aa}ne, the Freemasons Lodge of Instruction EOS in Lund, the Foundation of F{\"a}rs & Frosta—Sparbanken Sk{\aa}ne, and the Swedish Stroke Association. SD is supported by grants from the Agence Nationale de la Recherche, the Joint Programme on Neurodegenerative Disease research, the European Research Council, and the Initiative of Excellence of University of Bordeaux. JM, JJ-C, and KC declare no competing interests.",
year = "2018",
month = aug,
doi = "10.1016/S1474-4422(18)30243-6",
language = "English (US)",
volume = "17",
pages = "663--665",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "8",
}